FT Markets Data
Mediclinic International PLC

Form 8.5 (EPT/RI)-Replacement of Mediclinic

Source: RNS
RNS Number : 9713H
Morgan Stanley & Co. Int'l plc
29 November 2022
 

AMENDMENT(2(b))

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mediclinic International plc

(d) Date dealing undertaken:

25 November 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

PURCHASES

417,805

4.9680 GBP

4.9440 GBP

10p ordinary

SALES

238,038

4.9680 GBP

4.9455 GBP

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

increasing a long position

1,837

101.9564 ZAR

10p ordinary

CFD

increasing a long position

9,654

102.0194 ZAR

10p ordinary

CFD

increasing a long position

1,111

102.0618 ZAR

10p ordinary

CFD

increasing a long position

61,260

102.0680 ZAR

10p ordinary

CFD

increasing a long position

1,413

102.1133 ZAR

10p ordinary

CFD

increasing a long position

4,317

4.9673 GBP

10p ordinary

CFD

increasing a short position

21,527

102.0715 ZAR

10p ordinary

CFD

increasing a short position

37,167

4.9493 GBP

10p ordinary

CFD

increasing a short position

29,528

4.9493 GBP

10p ordinary

CFD

increasing a short position

123,267

4.9493 GBP

10p ordinary

CFD

increasing a short position

10,038

4.9493 GBP

10p ordinary

CFD

increasing a short position

572

4.9535 GBP

10p ordinary

CFD

increasing a short position

25

4.9680 GBP

10p ordinary

CFD

reducing a long position

3,895

102.0217 ZAR

10p ordinary

CFD

reducing a long position

14,015

102.0239 ZAR

10p ordinary

CFD

reducing a long position

18,990

102.0555 ZAR

10p ordinary

CFD

reducing a long position

11,805

102.0715 ZAR

10p ordinary

CFD

reducing a long position

2,108

102.0808 ZAR

10p ordinary

CFD

reducing a long position

2,935

102.1614 ZAR

10p ordinary

CFD

reducing a long position

11

4.9482 GBP

10p ordinary

CFD

reducing a long position

2

4.9520 GBP

10p ordinary

CFD

reducing a long position

240

4.9680 GBP

10p ordinary

CFD

reducing a short position

4,075

4.9462 GBP

10p ordinary

CFD

reducing a short position

9,125

4.9462 GBP

10p ordinary

CFD

reducing a short position

902

4.9480 GBP

10p ordinary

CFD

reducing a short position

572

4.9500 GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

29 November 2022
Contact name:

Craig Horsley
Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFLFSSLRLAFIF